RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Maxigen Biotech Stock

Maxigen Biotech Dividend 2024

Maxigen Biotech Dividend

0.48 TWD

Maxigen Biotech Dividend yield

1.13 %

Ticker

1783.TW

ISIN

TW0001783009

How much dividend does Maxigen Biotech 2024 pay?

According to the latest status from November 2024, Maxigen Biotech paid a total of 0.48 TWD per share in dividends within the last 12 months. With the current Maxigen Biotech price of 42 TWD, this corresponds to a dividend yield of 1.13 %. A dividend is paid times per year.

1.13 % Dividend Yield=
0.48 TWD Dividend
42 TWD Stock Price

Historical Maxigen Biotech Dividends

A dividend is paid times per year. Last year, the payout months were and October.

PaydateDividend
8/23/20241
10/7/20230.48
9/19/20210.73
9/6/20200.78
8/24/20190.68
8/24/20180.15
1

Maxigen Biotech dividend history and estimates

In 2023, Maxigen Biotech paid a dividend amounting to 0.48 TWD. Dividend means that Maxigen Biotech distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Maxigen Biotech provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Maxigen Biotech’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Maxigen Biotech's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Maxigen Biotech Dividend History

DateMaxigen Biotech Dividend
20230.48 undefined
20210.66 undefined
20200.71 undefined
20190.62 undefined
20180.14 undefined

Is the Maxigen Biotech Dividend Safe?

Maxigen Biotech has been increasing the dividend for 3 years.

Over the past 10 years, Maxigen Biotech has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 28.352%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Maxigen Biotech dividend payout ratio

In 2023, Maxigen Biotech had a payout ratio of 78.13%. The payout ratio indicates the percentage of the company's profits that Maxigen Biotech distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Maxigen Biotech represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Maxigen Biotech could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Maxigen Biotech's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Maxigen Biotech Payout Ratio History

DateMaxigen Biotech Payout ratio
202378.13 %
202280.38 %
202163.7 %
202090.31 %
201987.13 %
201820.71 %
201780.38 %
201680.38 %
201580.38 %
201480.38 %
201380.38 %
201280.38 %
201180.38 %
201080.38 %
200980.38 %
200880.38 %

Dividend Details

Understanding Maxigen Biotech's Dividend Distributions

Maxigen Biotech’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Maxigen Biotech's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Maxigen Biotech's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Maxigen Biotech’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Maxigen Biotech Aktienanalyse

What does Maxigen Biotech do?

Maxigen Biotech Inc is a biotechnology company that was founded in 2000. The company, based in San Francisco, California, specializes in the development and production of biotechnological products and solutions. The company's goal is to lead in the biotechnology industry and have a positive impact on the health and well-being of people. To achieve its goals, the company has specialized in four business areas. The first business area is the research and development of new biotechnological products. The company has a team of scientists who work continuously on new innovative technologies and products. The company has already brought several products to market that have been very successful in the biotechnology industry. The second business area is the production of biotechnological products. The company has its own production facility equipped with state-of-the-art technologies. Here, the company's products are manufactured and delivered to customers worldwide. The third business area is the distribution of biotechnological products. The company has built a large distribution network to distribute its products in different parts of the world. The company works closely with pharmacies, laboratories, and hospitals to ensure that its products are made accessible to people. The fourth business area is the application of biotechnological products. The company works closely with doctors and healthcare facilities to ensure that its products are used in medical practice. The company is committed to using its products to improve the health and well-being of people worldwide. Maxigen Biotech Inc has introduced some remarkable products to the market in its history. One of the company's most important products is a highly effective antibiotic used to fight bacterial infections. The company has also developed a medication for the treatment of hypertension that is in high demand worldwide. Additionally, the company has developed a range of products for the treatment of cancer and other serious illnesses. The company has also made a significant contribution to public health. The company has developed technology to lower cholesterol levels in the blood, which can help prevent cardiovascular diseases. The company has also worked on the development of vaccines against infectious diseases that are still prevalent in some regions of the world. Maxigen Biotech Inc has received numerous awards and recognition in its history. The company is known for its innovation and high quality in the production of its products. The company is an example of how the biotechnology industry can contribute to improving the health and well-being of people worldwide. In summary, Maxigen Biotech Inc is a biotechnology company that specializes in the development and production of biotechnological products and solutions. The company has specialized in four business areas: research and development of new products, production of biotechnological products, distribution of biotechnological products, and application of biotechnological products. The company has introduced some remarkable products to the market in its history and has made a significant contribution to public health. The company has received numerous awards and recognition and is an example of excellence in the biotechnology industry. Maxigen Biotech is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Maxigen Biotech stock

How much dividend does Maxigen Biotech pay?

Over the past 12 months, Maxigen Biotech paid a dividend of 0.48 TWD . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, Maxigen Biotech is expected to pay a dividend of 0.48 TWD.

What is the dividend yield of Maxigen Biotech?

The current dividend yield of Maxigen Biotech is 1.13 %.

When does Maxigen Biotech pay dividends?

Maxigen Biotech pays a quarterly dividend. This is distributed in the months of September, September, October, August.

How secure is the dividend of Maxigen Biotech?

Maxigen Biotech paid dividends every year for the past 1 years.

What is the dividend of Maxigen Biotech?

For the upcoming 12 months, dividends amounting to 0.48 TWD are expected. This corresponds to a dividend yield of 1.13 %.

In which sector is Maxigen Biotech located?

Maxigen Biotech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Maxigen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Maxigen Biotech from 8/16/2024 amounting to 0.999 TWD, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Maxigen Biotech pay the last dividend?

The last dividend was paid out on 8/16/2024.

What was the dividend of Maxigen Biotech in the year 2023?

In the year 2023, Maxigen Biotech distributed 0.664 TWD as dividends.

In which currency does Maxigen Biotech pay out the dividend?

The dividends of Maxigen Biotech are distributed in TWD.

Andere Kennzahlen von Maxigen Biotech

Our stock analysis for Maxigen Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Maxigen Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.